BGACF (BioNeutra Global) Total Stockholders Equity: $-6.08 Mil (As of Sep. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is BioNeutra Global Total Stockholders Equity?

BioNeutra Global BGACF Total Stockholders Equity is $-6.08 Mil as of Sep. 2024.

BioNeutra Global's Total Stockholders Equity for the quarter that ended in Sep. 2024 was $-6.08 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. BioNeutra Global's Book Value per Share for the quarter that ended in Sep. 2024 was $-0.13. The ratio of a company's debt over equity can be used to measure how leveraged this company is. BioNeutra Global's Debt-to-Equity for the quarter that ended in Sep. 2024 was -0.92.

BioNeutra Global  (OTCPK:BGACF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

BioNeutra Global's Book Value per Share for the quarter that ended in Sep. 2024 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-6.076-0)/46.449
=-0.13

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

BioNeutra Global's Debt-to-Equity for the quarter that ended in Sep. 2024 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.689 + 4.879) / -6.076
=-0.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioNeutra Global Total Stockholders Equity Related Terms

BioNeutra Global Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for BioNeutra Global's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioNeutra Global Total Stockholders Equity Chart

BioNeutra Global Annual Data
Trend Feb14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.61 0.55 -0.81 -2.77 -4.62

BioNeutra Global Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.54 -4.62 -5.17 -5.69 -6.08
What does a Total Stockholders Equity of $-6.08 Mil mean?
BioNeutra Global (BGACF) has a Total Stockholders Equity of $-6.08 Mil as of Sep. 2024. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for BioNeutra Global and its competitors.
Is BioNeutra Global's Total Stockholders Equity too high?
BioNeutra Global's current Total Stockholders Equity is $-6.08 Mil.
How does BioNeutra Global's Total Stockholders Equity compare to ARRT and BSFC?
BioNeutra Global's Total Stockholders Equity of $-6.08 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Consumer Packaged Goods company?
A good Total Stockholders Equity depends on the Consumer Packaged Goods industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for BioNeutra Global and its competitors. BioNeutra Global's current Total Stockholders Equity is $-6.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioNeutra Global stock overvalued right now?
BioNeutra Global (BGACF) has a current Total Stockholders Equity of $-6.08 Mil. The current Total Stockholders Equity is $-6.08 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For BioNeutra Global (BGACF), the current Total Stockholders Equity is $-6.08 Mil as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioNeutra Global Business Description

Address 1101-1030 West Georgia Street, Vancouver, BC, CAN, V6E 2Y3
BioNeutra Global Corp is engaged in the research, development, production, and commercialization of food ingredients for neutraceutical, functional and mainstream foods, focusing on oligosaccharides. Its product portfolio provides ingredients for various food systems, that contribute to human nutrition and wellness in functional and healthy foods. Its prime product, VitaFiber IMO, is offered in both powder and syrup form. The company operates in Canada while generating sales revenue from various countries internationally. It has a single industry segment, manufacturing and trading of products. The majority of the revenue is derived from the United States.